findmyKOL
Clinical trialNCT04360096TerminatedPhase 2/PHASE3Interventional

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

SponsorAPR Applied Pharma Research s.a.Enrollment144ALIARDSAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)COVIDDyspneaSARS-CoV 2
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • St. Jude Medical Center

    Fullerton, California, United States

  • University of California - Irvine

    Irvine, California, United States

  • University of Miami Leonard M. Miller School of Medicine (ummsm)

    Miami, Florida, United States

  • Advent Health Research Institute

    Orlando, Florida, United States

  • Northwestern Medical Group

    Winfield, Illinois, United States

  • University of Louisville Hospital

    Louisville, Kentucky, United States

  • Great Plains Health

    North Platte, Nebraska, United States

  • University Medical Center

    Las Vegas, Nevada, United States

  • Holy Name Medical Center

    Teaneck, New Jersey, United States

  • Kettering Health Network

    Kettering, Ohio, United States

  • Doylestown Hospital

    Doylestown, Pennsylvania, United States

  • Self Regional Healthcare

    Greenwood, South Carolina, United States

  • University of Texas San Antonio Medical Arts and Research Center

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Feb 2021
Primary completion
15 Dec 2021
Completion
31 Dec 2021
Last update posted
3 Feb 2023
Registered enrollment
144
Registry id
NCT04360096

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.